Dublin, July 10, 2018 (GLOBE NEWSWIRE) -- The "Automated and Rapid Microbiological Tests - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.
This report analyzes the worldwide markets in US$ Thousand by the following End-Use Segments:
- Clinical Applications (Automated Identification & Susceptibility Systems, Automated Blood Culture Systems, Automated Tuberculosis Systems, Streptococcal Infection Rapid Tests, GC/Chlamydia Rapid Tests, & Other Automated & Rapid Microbiological Tests)
- Non-Clinical Applications
The report profiles 83 companies including many key and niche players such as:
- Abbott Laboratories (US)
- Abbott Molecular, Inc. (US)
- Alere Inc. (US)
- Beckman Coulter, Inc. (US)
- Becton Dickinson and Company (US)
- bioMerieux SA (France)
- bioMerieux, Inc. (US)
- Bio-Rad Laboratories, Inc (US)
- Cellabs Pty Ltd (Australia)
- Cepheid Inc. (US)
- CorisBioconcept SPRL (Belgium)
- F. Hoffmann-La Roche AG (Switzerland)
- Hologic, Inc. (US)
- MedMira Inc. (Canada)
- Meridian Bioscience, Inc. (US)
- OraSure Technologies, Inc. (US)
- Orion Diagnostica Oy (Finland)
- QIAGEN N.V. (The Netherlands)
- Quidel Corporation (US)
- Sekisui Diagnostics, LLC (US)
- Siemens Healthcare GmbH (Germany)
- Thermo Fisher Scientific Inc. (US)
- Oxoid Limited (UK)
Key Topics Covered
1. INDUSTRY OVERVIEW
Global In-Vitro Diagnostics Market
Central Laboratories Dominate the Market
Immunochemistry
the Leading Segment
Automated and Rapid Microbiological Tests Revolutionize Microbiological Testing
Evolutionary Battle against Microbes Drives Market Future
Automated Microbiological Tests: A Pesky Gray Area in the Clinical Diagnostics Market
Instant Detection of Pathogens
A New Epoch in the Fight for Survival
Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
Emerging Markets Provide Tremendous Growth Opportunities
Clinical Applications
Non-Clinical Applications
A Holistic Peek into a Few Noteworthy Trends
The Evolution of Biotechnology
A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests
Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential
2. COMPETITION
Competitive Dynamics in the C. Difficile Testing Market
List of Select Molecular C. difficile Test Products
3. MARKET DRIVERS AND TRENDS
Increasing Incidence of Infectious Diseases
An Opportunity Indicator
Rising Healthcare Needs of Aging Global Population
A Growth Driver
The World is Ageing
Rising HIV Prevalence
A Key Opportunity Indicator
Some Significant HIV Statistics by Region: 2015
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
Ultra-Rapid HIV-Screening Tests put up a Strong Fight against HIV-Epidemic
Accuracy/Reliability of Home HIV Testing: A Bone of Contention
Increase in Healthcare Spending in Emerging Markets to Propel Demand
Rising Emphasis on Lab Automation to Augur Well for Market Growth
Greater Patient Awareness to Drive Growth
Advancements in Molecular Diagnostics
A Boon
Antibiotic Resistant Bacteria Throws the Spotlight on Microbial Testing
Influenza
Boosting Rapid Test Prospects
Select FDA-approved Rapid Detection Tests for Flu A&B: (2015)
Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
Impact of Food Scares on Rapid Microbiological Tests Market
Stringent Norms Necessitate Microbial Food Safety Testing
Rapid Screening Gains Preference over Traditional Food Testing Procedures
Conventional Testing Continues to Dominate but Rapid Tests Making Inroads
Leading Food Processors Resort to Rapid Microbiological Testing
Food Packages of the Future Ingrained with Microbial Alert Systems
Poultry Industry Embraces Rapid Microbiological Testing Technologies
Rapid Microbiological Tests Gain Significance in the Pharma Industry
Key Advantages of Rapid Microbiological Tests for Pharma- In a Nutshell
Growth Direct System Creates Waves in Pharmaceutical Quality Control
4. KEY ISSUES CONFRONTING THE RAPID MICROBIOLOGICAL TESTS MARKET
Validation: An Imperative Prerequisite
Obtaining Regulatory Approval: A Major Non-Technical Hindrance
Non-Conformance to Testing Requirements: A Weighty Concern
Technical and Cost Issues Impede the Uptake of Rapid Microbiological Tests in the Food Sector
5. PRODUCT/TECHNOLOGY OVERVIEW
6. APPLICATION AREAS OF AUTOMATED AND RAPID MICROBIOLOGICAL TESTS - A REVIEW
Clinical Applications
Automated Identification and Susceptibility Systems
Automated Blood Culture Systems
Automated Tuberculosis Systems
Streptococcus Infection Rapid Tests
GC/Chlamydia Rapid Tests
Other Automated & Rapid Microbiological Tests
Applications in Non-Clinical Investigations
Food/Water Safety Tests
Rapid Microbiological Methods in Pharmaceutical Sector
Environmental Tests
Other Miscellaneous Applications
7. PRODUCT INNOVATIONS/INTRODUCTIONS
bioMrieux Launches New Platform for Extraction of DNA and RNA
Bio-Rad Launches IH-1000 Blood Typing System
bioMrieux Launches "EviSight Compact" Incubator System
BD Launches Next Generation Automated ID/AST System
Sekisui Introduces SEKURE TPLA and RPR Assays for Syphilis Testing
BD Introduces BD Veritor Plus System
Rhoenix Introduces Beer SpoilerAlert Assay
Philips Introduces Minicare
System
Bio-Rad Introduces Amplichek II Quality Control
Bruker Launches Enhancements for MALDI Biotyper
Thermo Fisher Launches Thermo Scientific SureTect Cronobacter Species Real-Time PCR Assay
Hologic Introduces Aptima Mycoplasma Genitalium Assay
bioMrieux and Illumina Introduce bioMrieux EpiSeq
bioMrieux Launches GENE-UP
BioControl Launches Modular Automation for Assurance GDS
Rapid Micro Biosystems Launches Growth Direct System
IDEXX Launches Quanti-Tray Sealer PLUS in Europe
Sekisui Introduces 3 New Assays to the OSOM Rapid Test Line
Bio-Rad Launches IH-500
bioMrieux Launches VIDAS Lyme IgG II and VIDAS Lyme IgM II Assays in the US
Meridian Introduces illumigene HSV Assays in Europe
Medicinal Genomics Introduces PathogINDICAtor Assay
Roche Introduces cobas DPX Test
8. RECENT INDUSTRY ACTIVITY
Abbott Files for Cancellation of Acquisition Agreement with Alere
Hologic Obtains CE Mark Approval for Aptima HSV Assay
Hologic Obtains Health Canada Approval for Aptima Hepatitis C and B Quant Assays
Quidel Obtains FDA Approval for Solana Assay for Various Streptococcus Strains
Quidel Obtains FDA Approval for Solana Assay for Influenza A&B
BD Receives FDA Approval for BD MAX CT/GC/TV Assay
OraSure Obtains BARDA Funding for Zika Tests
Alere Obtains FDA Approval for Alere i RSV Rapid Molecular Test
Magellan Diagnostics Obtains Chinese Approval for LeadCare II
Alere Receives CE Mark for Alere Reader
Sekisui Secures Distribution Rights for FastPack IP System from Qualigen
bioMrieux Submits 510(k) Application for BacT/ALERT VIRTUO
Alere Begins Operations at New Facility in India
Alere Obtains WHO Prequalification for Alere HIV Combo
Hologic and Grifols Receive FDA Approval for Procleix Zika Virus Assay
Meridian Obtains FDA Approval for illumigene Mycoplasma Direct Assay
Alere Announces WHO Prequalification for Alere q HIV-1/2 Detect Assay
BD and Check-Points Enter into Development and Distribution Agreement
Luminex to Acquire Nanosphere
bioMrieux Takes Over Hyglos
BD Receives CE Mark for BD MAX Vaginal Panel
Siemens Healthcare Changes Name to Siemens Healthineers
Sekisui and Qualigen Enter into Partnership
Meridian Obtains CE Mark for illumigene Mycoplasma Direct
BioFire Obtains FDA and CE Mark Approval for FilmArray Torch use with all FilmArray Panels
Roche Receives FDA IND Approval for cobas Zika Assay
Meridian Takes Over Magellan Biosciences
Thermo Fisher Obtains FDA Approval for B - R - A - H - M - S PCT Assay for Sepsis Risk Assessment
BioFire Obtains FDA Approval for FilmArray Torch for use with FilmArray Respiratory Panel
Abbott Signs Acquisition Agreement with Alere
Siemens Receives FDA Approval for Sysmex CS-2100i System
Bio-Rad Receives FDA Approval for TANGO infinity system
Bio-Rad Obtains FDA Approval for D-100 System for A1c Testing
MedMira Obtains FDA Approval for Reveal G4 Rapid HIV-1 Antibody Test
FDA Approves cobas HBV and cobas HCV Viral Load Tests for cobas 6800 and cobas 8800 Systems
Hologic Obtains CE-IVD Certification for Aptima HCV Quant Dx Assay on Panther System
BD and Seegene Enter into Collaboration Agreement
FDA Emergency Authorization for OraSure OraQuick Ebola Rapid Antigen Test
Bio-Rad Obtains Pre-Market Approval for BioPlex 2200 HIV Ag-Ab Assay
FDA Approves VIDAS 3 Immunoassay from bioMrieux
Meridian Obtains FDA Approval for illumigene HSV 1&2
Charles River Laboratories Acquires Celsis International
FDA Approves Quidel Solana Molecular System and Solana Molecular Assay
FDA Approves Roche cobas HSV 1 and 2 Test
FDA Approves Roche cobas Cdiff Test
MedMira Submits Supplement for FDA Approval of Reveal G4 Rapid HIV-1 Antibody Test
FDA Approves Alere i Strep A Rapid Molecular Test
bioMrieux Acquires CREERAM Tools
FDA Gives CLIA Waiver Alere i Influenza A & B Test
Alere Obtains CE Mark Approval for Alere HIV Combo
Alere Obtains IVD CE Mark Approval for Alere q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care
FDA Gives CLIA Waiver for Alere i Strep A Rapid Molecular Test
BioFire Obtains FDA Approval and CE-IVD Marking for FilmArray 2.0 System
FDA Approves Next Generation cobas MRSA/SA Test of Roche
FDA Approves cobas TaqScreen MPX Test, v2.0 of Roche
bioMrieux Signs Strategic Agreement with COPAN
9. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Laboratories (US)
Abbott Molecular, Inc. (US)
Alere Inc. (US)
Beckman Coulter, Inc. (US)
Becton Dickinson and Company (US)
bioMrieux SA (France)
bioMerieux, Inc. (US)
Bio-Rad Laboratories, Inc (US)
Cellabs Pty Ltd (Australia)
Cepheid Inc. (US)
CorisBioconcept SPRL (Belgium)
F. Hoffmann-La Roche AG (Switzerland)
Hologic, Inc. (US)
MedMira Inc. (Canada)
Meridian Bioscience, Inc. (US)
OraSure Technologies, Inc. (US)
Orion Diagnostica Oy (Finland)
QIAGEN N.V. (The Netherlands)
Quidel Corporation (US)
Sekisui Diagnostics, LLC (US)
Siemens Healthcare GmbH (Germany)
Thermo Fisher Scientific Inc. (US)
Oxoid Limited (UK)
10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 83 (including Divisions/Subsidiaries -90)
- The United States (55)
- Canada (1)
- Japan (4)
- Europe (27)
- France (3)
- Germany (9)
- The United Kingdom (3)
- Italy (2)
- Spain (1)
- Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (2)
- Middle East (1)
For more information about this report visit https://www.researchandmarkets.com/research/p682tw/global_automated?w=12